{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:15:30Z","timestamp":1791828930910,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2024-00468,417"],"award-info":[{"award-number":["RS-2024-00468,417"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2023-00252049"],"award-info":[{"award-number":["RS-2023-00252049"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2026-25486519"],"award-info":[{"award-number":["RS-2026-25486519"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2024-00457100"],"award-info":[{"award-number":["RS-2024-00457100"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2024-00339811"],"award-info":[{"award-number":["RS-2024-00339811"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020850","name":"College of Science, Sungkyunkwan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002647","name":"Sungkyunkwan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002647","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.yexcr.2026.115070","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:55:51Z","timestamp":1778889351000},"page":"115070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel chalcone analog inhibits cancer stemness in CD44+ and CD133+ populations via suppression of ERK signaling"],"prefix":"10.1016","volume":"460","author":[{"given":"Suji","family":"Baek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seojin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7681-0572","authenticated-orcid":false,"given":"Seo Lyn","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Yoon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bom Sahn","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Hyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hyuk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Seok","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5940-3430","authenticated-orcid":false,"given":"Chang-Whan","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang Pa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2026.115070_bib1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.yexcr.2026.115070_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.yexcr.2026.115070_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2026.115070_bib4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2026.115070_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"issue":"19","key":"10.1016\/j.yexcr.2026.115070_bib6","article-title":"Drug resistance and cancer stem cells","volume":"19","author":"Li","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.yexcr.2026.115070_bib7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","article-title":"EMT, CSCs, and drug resistance: the mechanistic link and clinical implications","volume":"14","author":"Shibue","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2026.115070_bib8","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.18632\/oncotarget.4037","article-title":"EMT, CTCs and CSCs in tumor relapse and drug-resistance","volume":"6","author":"Mitra","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2026.115070_bib9","first-page":"1124","article-title":"Cancer stem cells revisited","volume":"23","author":"Batlle","year":"2017","journal-title":"Nat. Med. (N. Y., NY, U. S.)"},{"key":"10.1016\/j.yexcr.2026.115070_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","article-title":"Cancer stem cells: advances in knowledge and implications for cancer therapy","volume":"9","author":"Chu","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.yexcr.2026.115070_bib11","article-title":"Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment","volume":"2018","author":"Phi","year":"2018","journal-title":"Stem Cell. Int."},{"key":"10.1016\/j.yexcr.2026.115070_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2013.11.012","article-title":"Cancer stem cells: a contentious hypothesis now moving forward","volume":"344","author":"O'Connor","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2026.115070_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.stem.2018.12.009","article-title":"Cancer stem cells: the architects of the tumor ecosystem","volume":"24","author":"Prager","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yexcr.2026.115070_bib14","doi-asserted-by":"crossref","first-page":"35141","DOI":"10.18632\/oncotarget.6177","article-title":"Metabolic plasticity of cancer stem cells","volume":"6","author":"Luo","year":"2015","journal-title":"Oncotarget"},{"issue":"20","key":"10.1016\/j.yexcr.2026.115070_bib15","article-title":"Cancer stem cells as key drivers of tumour progression","volume":"25","author":"Ayob","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.yexcr.2026.115070_bib16","first-page":"1","article-title":"Multi-pathway therapeutics in colorectal cancer: targeting EMT, CSCs, and non-apoptotic cell death for drug resistance reversal","author":"Hu","year":"2025","journal-title":"J. Drug Target."},{"key":"10.1016\/j.yexcr.2026.115070_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.stem.2018.11.017","article-title":"Targeting cancer stemness in the clinic: from hype to hope","volume":"24","author":"Saygin","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yexcr.2026.115070_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","article-title":"Tumour stem cells and drug resistance","volume":"5","author":"Dean","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2026.115070_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature05384","article-title":"Identification and expansion of human colon-cancer-initiating cells","volume":"445","author":"Ricci-Vitiani","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2026.115070_bib20","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2026.115070_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12935-025-03748-4","article-title":"CD44 on cancer stem cell is a potential immunological and prognostic pan-cancer biomarker","volume":"25","author":"Zhu","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.yexcr.2026.115070_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2026.115070_bib23","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1158\/1535-7163.MCT-10-0530","article-title":"More than markers: biological significance of cancer stem cell-defining molecules","volume":"9","author":"Keysar","year":"2010","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.yexcr.2026.115070_bib24","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1021\/acs.chemrev.7b00020","article-title":"Chalcone: a privileged structure in medicinal chemistry","volume":"117","author":"Zhuang","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.yexcr.2026.115070_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejmech.2006.09.019","article-title":"A review of anti-infective and anti-inflammatory chalcones","volume":"42","author":"Nowakowska","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.yexcr.2026.115070_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157488410790410579","article-title":"Trends in utilization of the pharmacological potential of chalcones","volume":"5","author":"Batovska","year":"2010","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.yexcr.2026.115070_bib27","first-page":"42","article-title":"The development of chalcones as promising anticancer agents","volume":"10","author":"Ducki","year":"2007","journal-title":"Idrugs"},{"key":"10.1016\/j.yexcr.2026.115070_bib28","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2174\/1871520623666230223112530","article-title":"Recent progresses in chalcone derivatives as potential anticancer agents","volume":"23","author":"Yang","year":"2023","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.yexcr.2026.115070_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/biom11060894","article-title":"Chalcone derivatives: role in anticancer therapy","volume":"11","author":"Ouyang","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.yexcr.2026.115070_bib30","first-page":"1","article-title":"Molecular and pharmacological mechanisms of drug resistance:an evolving paradigm","volume":"249","author":"Colmegna","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.yexcr.2026.115070_bib31","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2026.115070_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1160068","article-title":"Therapy-resistant breast cancer in focus: clinically relevant mitigation by flavonoids targeting cancer stem cells","volume":"14","author":"Mazurakova","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yexcr.2026.115070_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262412082","article-title":"The role of natural chalcones and their derivatives in targeting prostate cancer: recent updates","volume":"26","author":"Hussein","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2026.115070_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210354","article-title":"Anticancer potential of natural chalcones: in vitro and in vivo evidence","volume":"24","author":"Michalkova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2026.115070_bib35","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2026.115070_bib36","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock 4 and AutoDockTools 4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.yexcr.2026.115070_bib37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.yexcr.2026.115070_bib38","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/pro.3902","article-title":"PyXlinkViewer: a flexible tool for visualization of protein chemical crosslinking data within the PyMOL molecular graphics system","volume":"29","author":"Schiffrin","year":"2020","journal-title":"Protein Sci."},{"key":"10.1016\/j.yexcr.2026.115070_bib39","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s11605-022-05568-7","article-title":"Patient-derived organoids from locally advanced gastric adenocarcinomas can predict resistance to neoadjuvant chemotherapy","volume":"27","author":"Yoon","year":"2023","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.yexcr.2026.115070_bib40","first-page":"1607","article-title":"A rectal cancer organoid platform to study individual responses to chemoradiation","volume":"25","author":"Ganesh","year":"2019","journal-title":"Nat. Med. (N. Y., NY, U. S.)"},{"key":"10.1016\/j.yexcr.2026.115070_bib41","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.yexcr.2026.115070_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17111873","article-title":"An organoid model for translational cancer research recapitulates histoarchitecture and molecular hallmarks of non-small-cell lung cancer","volume":"17","author":"Ekanger","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.yexcr.2026.115070_bib43","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jnci\/djn123","article-title":"Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy","volume":"100","author":"Li","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.yexcr.2026.115070_bib44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature05372","article-title":"A human Colon cancer cell capable of initiating tumour growth in immunodeficient mice","volume":"445","author":"O'Brien","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2026.115070_bib45","first-page":"5821","article-title":"Identification of a cancer stem cell in human brain tumors","volume":"63","author":"Singh","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115070_bib46","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature07733","article-title":"Association of reactive oxygen species levels and radioresistance in cancer stem cells","volume":"458","author":"Diehn","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2026.115070_bib47","doi-asserted-by":"crossref","DOI":"10.1177\/15347354251407216","article-title":"Exercise as precision medicine: targeting HER2\/CD44-Driven therapy resistance in breast cancer (A mini review)","volume":"25","author":"Edalat Haghi","year":"2026","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.yexcr.2026.115070_bib48","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1158\/1078-0432.CCR-15-2665","article-title":"CD44+ cells in head and neck squamous cell carcinoma suppress T-Cell-Mediated immunity by selective constitutive and inducible expression of PD-L1","volume":"22","author":"Lee","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115070_bib49","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/stem.30","article-title":"Identification of gastric cancer stem cells using the cell surface marker CD44","volume":"27","author":"Takaishi","year":"2009","journal-title":"Stem Cell."},{"key":"10.1016\/j.yexcr.2026.115070_bib50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.17116\/patol2024860515","article-title":"[ALDH1, CD133, CD34-positive cancer stem cells in lung adenocarcinoma in patients who had a new coronavirus infection and retained the persistence of viral proteins in the lung tissue]","volume":"86","author":"Kogan","year":"2024","journal-title":"Arkh. Patol."},{"key":"10.1016\/j.yexcr.2026.115070_bib51","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/15384047.2021.1916381","article-title":"The role of CD133 in hepatocellular carcinoma","volume":"22","author":"Liu","year":"2021","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.yexcr.2026.115070_bib52","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejmech.2006.09.019","article-title":"A review of anti-infective and anti-inflammatory chalcones","volume":"42","author":"Nowakowska","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.yexcr.2026.115070_bib53","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.intimp.2010.12.006","article-title":"The role of chalcones in suppression of NF-kappaB-mediated inflammation and cancer","volume":"11","author":"Yadav","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.yexcr.2026.115070_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157488410790410579","article-title":"Trends in utilization of the pharmacological potential of chalcones","volume":"5","author":"Batovska","year":"2010","journal-title":"Curr. Clin. Pharmacol."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726001874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726001874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:06:11Z","timestamp":1783069571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482726001874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0014482726001874"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115070","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel chalcone analog inhibits cancer stemness in CD44+ and CD133+ populations via suppression of ERK signaling","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115070"}}